We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-14.56%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$688M
AUM Growth
-$52M
Cap. Flow
-$179M
Cap. Flow %
-26.07%
Top 10 Hldgs %
65.57%
Holding
231
New
46
Increased
68
Reduced
48
Closed
42

Top Buys

Rank Stock Value
1
AIOS
AIOS Tech
AIOS
+$28.5M
2
AGMH icon
AGM Group Holdings
AGMH
+$13.2M
3
OG
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
+$7.66M
4
ESPR
Esperion Therapeutics
ESPR
+$7.53M
5
CNTX icon
Context Therapeutics
CNTX
+$6.14M

Top Sells

Rank Stock Value
1
ZNB
Zeta Network Group
ZNB
+$3.39M
2
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$3.33M
3
TCDA
Tricida, Inc. Common Stock
TCDA
+$3.06M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$2.84M
5
FLUX icon
Flux Power
FLUX
+$2.59M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.53%
2 Healthcare 8.91%
3 Financials 5.9%
4 Technology 5.82%
5 Consumer Discretionary 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATHX
151
DELISTED
Athersys, Inc. Common Stock
ATHX
$105K 0.02%
4,658
– –
FCEL icon
152
CALL
FuelCell Energy
FCEL
$1.22B
$104K 0.02%
7
– –
CRDF icon
153
PUT
Cardiff Oncology
CRDF
$102M
$102K 0.01%
170
– –
BNKK
154
Bonk Inc
BNKK
$10.9M
$85K 0.01%
2,721
-9,077
-77% -$490K
NCTY
155
CALL
The9 Ltd
NCTY
$63.8M
$82K 0.01%
12
-17
-59% -$1.73K
IMG
156
PUT
DELISTED
CIMG Inc
IMG
– –
0
– –
NOVN
157
DELISTED
Novan, Inc. Common Stock
NOVN
$80K 0.01%
19,132
– –
BKYI
158
BIO-key International
BKYI
$3.81M
$78K 0.01%
197
+86
+77% +$43.4K
UK icon
159
Ucommune International Ltd Class A Ordinary Shares
UK
$1.38M
$69K 0.01%
42
-82
-66% -$167K
PALI icon
160
Palisade Bio
PALI
$357M
$68K 0.01%
70
– –
BIOC
161
DELISTED
Biocept, Inc.
BIOC
$68K 0.01%
+622
New +$71.6K
RCAT icon
162
CALL
Red Cat Holdings
RCAT
$1.19B
$65K 0.01%
+312
New +$778
ANY icon
163
CALL
Sphere 3D
ANY
$25.5M
$56K 0.01%
+3
New +$1.16K
RKDA icon
164
PUT
Arcadia Biosciences
RKDA
$1.04M
$56K 0.01%
13
-70
-84% -$4.56K
EVFM
165
PUT
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$52K 0.01%
92
+44
+92% +$374
CTXR icon
166
Citius Pharmaceuticals
CTXR
$15.9M
$48K 0.01%
+1,235
New +$56K
EVOK
167
DELISTED
Evoke Pharma
EVOK
$48K 0.01%
611
+42
+7% +$5.88K
BRTX icon
168
BioRestorative Therapies
BRTX
$3.69M
$43K 0.01%
+500
New +$57.1K
WIMI
169
WiMi Hologram Cloud
WIMI
$18.9M
$43K 0.01%
1,420
-36,959
-96% -$1.49M
NBRV
170
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$40K 0.01%
2,682
+1,213
+83% +$28.7K
NBRV
171
PUT
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$40K 0.01%
27
-5
-16% -$118
ALPP
172
DELISTED
Alpine 4 Holdings Inc
ALPP
$39K 0.01%
+2,526
New +$56.1K
EQOS
173
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$39K 0.01%
20,799
-91,734
-82% -$355K
KUST
174
CALL
Kustom Entertainment Inc
KUST
$4.22M
– –
0
– –
ALPP
175
PUT
DELISTED
Alpine 4 Holdings Inc
ALPP
$28K ﹤0.01%
+18
New +$400
5 6
7
8 9

Similar funds

IWA
Independent Wealth Advisors Cary, North Carolina $111M AUM
BFA
Ballast Financial Advisors West Chester, Pennsylvania $110M AUM
WPWM
Western Pacific Wealth Management Lake Forest, Illinois $111M AUM 26.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
ZS
Zenith Solutions Philadelphia, Pennsylvania $110M AUM
KC
Karras Company Roy, Utah $110M AUM
FI
FinArc Investments Norwood, Massachusetts $110M AUM
CIM
Catalyst Investment Management Windham, New Hampshire $110M AUM

Sabby Management's Q4 2021 Portfolio in Review

As of Q4 2021, Sabby Management held 231 positions worth $688M, down 7% from $740M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Sabby Management withdrew a net $179M in Q4 2021, closing 42 positions and reducing 48 holdings. Its most notable exit was Tricida, Inc. Common Stock, an estimated $3.06M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, down from 77% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Sabby Management opened a new position in AIOS Tech worth $10.4M.

  • Sabby Management's largest Q4 2021 buy was AIOS Tech: 16,134 shares worth $10.4M.
  • Sabby Management added most to Acutus Medical Inc in Q4 2021, an estimated $3.52M increase.
  • Sabby Management's biggest Q4 2021 reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, cutting an estimated $3.33M.
  • Sabby Management fully exited Tricida, Inc. Common Stock in Q4 2021, selling an estimated $3.06M.
  • Sabby Management's ten largest holdings make up 66% of its $688M portfolio in Q4 2021.
  • Sabby Management opened 46 new positions and closed 42 in Q4 2021.
  • Sabby Management's portfolio value fell 7% quarter-over-quarter to $688M.

Based on Sabby Management's 13F filing for Q4 2021, filed 14 Feb 2022.